Skip to main content

Stifel Hires Konstantinos Aprilakis, M.D. as Managing Director Covering Biotech Sector

Written by Customer Service on . Posted in Public Companies.

ST. LOUIS, Aug. 25, 2020 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that Konstantinos N. Aprilakis, M.D. has joined the firm as a Managing Director and Senior Analyst covering the biotechnology sector. He is based in the firm’s New York office.
“We are thrilled to have Konstantinos on board as we continue to expand our biotech research team,” said Keith Gay, Director of Research. “Konstantinos has quickly proven himself to be an outstanding biotech analyst and one of the best in the rapidly growing oncology area.”Dr. Aprilakis was most recently a Director and Senior Biotechnology Research Analyst at Deutsche Bank. Prior to that, he was a Vice President and Senior Biotechnology Research Analyst at JMP Securities. He also has more than five years of experience in the medical research field, including stints at both Weill Cornell Medical College and Stony Brook University. Dr. Aprilakis received his Doctor of Medicine degree from Weill Cornell Medical College in 2014.“I am extremely excited to be joining Stifel,” said Dr. Aprilakis. “I’m particularly impressed by Stifel’s momentum in Healthcare, and look forward to continuing the expansion of Stifel’s biotech research effort.”Healthcare is currently the second largest sector of the S&P 500, and the addition of Dr. Aprilakis greatly enhances Stifel’s presence in this fast growing segment. With this hire, Stifel has a global research team of 36 healthcare professionals, including 10 senior analysts, covering 164 companies within the biotechnology, healthcare providers, medical technology & supplies, and specialty pharmaceutical sectors.In addition to providing outstanding research, Stifel also supports clients operating in or investing in the healthcare sector in multiple ways, including:Market making in more than 800 stocks across the healthcare spectrum, ranking the firm among the largest traders of public healthcare companies.
 An investment banking team with deep industry expertise, providing a full range of services to support growth companies in healthcare, raising over $68 billion in capital since 2010.Stifel Company InformationStifel Financial Corp. (NYSE: SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated, including its Eaton Partners business division; Keefe, Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC and Century Securities Associates, Inc. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank and Stifel Bank & Trust offer a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com. For global disclosures, please visit https://www.stifel.com/docs/pdf/pressreleases/press-release-disclosure.pdf.Media Contacts
Neil Shapiro, (212) 271-3447
shapiron@stifel.comJeff Preis, (212) 271-3749
preisj@stifel.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.